Lancet Series on the commercial determinants of health1 highlighted how commercial organisations shape health policies, both ...
Vaccination remains the most cost-effective public health intervention, preventing millions of deaths and reducing disease burden worldwide.1 However, their impact is rendered meaningless if vaccines ...
There is a growing opportunity to expand clinical research capacity in Africa, and numerous organisations are contributing to this effort. To name a few: the African Medicines Agency provides ...
On March 13, 2025, the UK Government announced that it was disbanding NHS England, the arm's length government body ...
Over the past decades, bronchiectasis has been neglected, despite the global burden.1,2 To date, better diagnosis due to easy ...
Population-based analyses of new vaccination programmes provide robust real-world evidence for post-licensure vaccine ...
In 2023, commitments made at the UN High-Level Meeting on the Fight Against Tuberculosis offered a renewed sense of hope and purpose after the COVID-19 pandemic.1 Nevertheless, tuberculosis disease ...
WHO issued a statement outlining the grave consequences of the US decision to drastically cut international funding for tuberculosis. WHO noted that countries with high burdens of tuberculosis disease ...
Asthma and atopic dermatitis are chronic inflammatory diseases of the airways and the skin, respectively, which affect hundreds of millions of children and adults globally. Most patients with asthma ...
Each day more than 500 children younger than 15 years die from tuberculosis. Considerable progress has been made to control tuberculosis, but the impact on reducing the burden of childhood ...
Overactive bladder is a chronic condition that affects 10–45% of women worldwide;1 however, more than half of women discontinue conservative and medical treatment.2,3 Predicting which women are better ...
In September, 2024, the Lancet Group updated our Editorial Manager submission portal to allow users to voluntarily assign equity, diversity, and inclusion classifications to submitted manuscripts or ...